“MIRACLE” DRUG LOW DOSE NALTREXONE HELPS MS, CANCER, & AUTOIMMUNE DISEASES, AIDS and MORE!

“MIRACLE” DRUG LOW DOSE NALTREXONE HELPS MS, CANCER, & AUTOIMMUNE DISEASES, AIDS AND MORE! – Low Dose Naltrexone is a “miracle” drug that is saving the lives of so many with immune diseases. Low Dose Naltrexone (LDN) is a form of Naltrexone, a drug used to treat drug and alcohol addiction. Dr. Ian Zagon, a brilliant researcher at Penn State, made the discovery that LDN in lower doses was a remarkable treatment for diseases that invoke a hyperactive immune response. LDN helps to quiet the system down. LDN boosts the body’s endorphin levels in the brain. It was found that those who suffer from numerous, immune deficiency disease have low endorphin levels. These naturally produced brain chemicals are released by the body in times of stress or to induce mood elevations. Every cell of the immune system has receptors for these agents. Studies with rats and humans has shown cancer cells to be inhibited by LDN. Many disorders such as MS, cancer, AIDS, fibromyalgia, IBS, chronic fatigue, ALS, autism, etc. are helped by LDN. There are approximately 50 diseases that can be helped by LDN. LDN must be filled by a compounding pharmacy in a non-time release formula. It is highly recommended that one of the pharmacies on lowdosenaltrexone.org fill the prescription. My prescription is filled at Skip’s Pharmacy. LDN is safe, effective, non addictive, virtually no side effects, and inexpensive, about .00 a day. The reason that most, including doctors, know nothing about it is because the patent has expired and the drug industry cannot make hugh profits. Therefore, they will not …

Supercharged chew is a tradition in the Yukon-Kuskokwim Delta

Filed under: drug rehab treatment- lowering the drinking age

What she found while treating patients in Western Alaska's largest city and the surrounding villages was something different: People of all ages, sometimes entire families, chewing an earthy, super-charged variety of smokeless tobacco. … "I've seen …
Read more on Anchorage Daily News